drugset / Trial / NCT01156220

Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers

NCT01156220

RandomizedParallel-groupOpen-labelTreatment

Summary

In this study the gender specificity of the effects of furosemide in female and male volunteers will be investigated. The main objective is gender-specific comparison of the pharmacokinetic parameters of furosemide in relation to the effect of furosemide (urinary excretion). Secondary objectives are the gender-specific comparison of renal and systemic PAH clearance with the clearance of furosemide and the influence of various genetic polymorphisms on the variability of furosemide pharmacokinetics.

Timeline

Start
2012-01
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminohippurate Sodium Diagnostic / imaging agent 500 mg Other
Subject Furosemide Other / unclassified 40 mg Other

Indications

No indication recorded.